GP73 links SARS-CoV-2 infection with dysglycaemia.

Nat Metab

Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Published: January 2022

Severe COVID-19 is often associated with detrimental elevations in blood glucose, but the mechanisms are poorly understood. In this issue of , Wan et al. identify GP73 as a SARS-CoV-2-induced secreted factor that enhances hepatic glucose production and is necessary for SARS-CoV-2-associated glucose abnormalities.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879606PMC
http://dx.doi.org/10.1038/s42255-021-00511-7DOI Listing

Publication Analysis

Top Keywords

gp73 links
4
links sars-cov-2
4
sars-cov-2 infection
4
infection dysglycaemia
4
dysglycaemia severe
4
severe covid-19
4
covid-19 associated
4
associated detrimental
4
detrimental elevations
4
elevations blood
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!